ENDRA Life Sciences Inc.

NDRA Nasdaq CIK: 0001681682

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 3600 GREEN COURT, ANN ARBOR, MI, 48105
Mailing Address 3600 GREEN COURT, ANN ARBOR, MI, 48105
Phone 734-335-0468
Fiscal Year End 1231
EIN 260579295

Financial Overview

FY2025

-$7.03M
Net Income

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 31, 2026 View on SEC
8-K Current report of material events March 25, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC
4 Insider stock transaction report January 23, 2026 View on SEC

Annual Reports

10-K March 31, 2026
  • Developing TAEUS®, a non-invasive, cost-effective ultrasound alternative for liver fat measurement.
  • Actively seeking a buyer or merger partner to address liquidity constraints.
View Analysis

Material Events

8-K Strategy Change March 31, 2026
High Impact
  • TAEUS® system successfully validated with accuracy matching MRI scans
  • Significant reduction in operating costs from $10.8M to $5.8M
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.